Identification of network motifs in lung disease Cecily Swinburne Mentor: Carol J. Bult Ph.D. Summer 2007.

Slides:



Advertisements
Similar presentations
Microarray statistical validation and functional annotation
Advertisements

Genetic Analysis of Genome-wide Variation in Human Gene Expression Morley M. et al. Nature 2004,430: Yen-Yi Ho.
The Cell Cycle and Cancer. Cell signaling: chemical communication between cells. Click on above to go to animation second chemical response inside the.
Gene regulation in cancer 11/14/07. Overview The hallmark of cancer is uncontrolled cell proliferation. Oncogenes code for proteins that help to regulate.
1 Harvard Medical SchoolMassachusetts Institute of Technology Identifying Differentially Expressed Genes in Time Series Microarrays Jonathan J. Smith 1.
1 MicroArray -- Data Analysis Cecilia Hansen & Dirk Repsilber Bioinformatics - 10p, October 2001.
Microarray technology and analysis of gene expression data Hillevi Lindroos.
Gene expression analysis summary Where are we now?
Microarrays Dr Peter Smooker,
Public data - available for projects 6 data sets: –Human Tissues –Leukemia –Spike-in –FARO compendium – Yeast Cell Cycle –Yeast Rosetta Find one yourself.
Gene Co-expression Network Analysis BMI 730 Kun Huang Department of Biomedical Informatics Ohio State University.
Microarrays and Cancer Segal et al. CS 466 Saurabh Sinha.
ONCOMINE: A Bioinformatics Infrastructure for Cancer Genomics
. Differentially Expressed Genes, Class Discovery & Classification.
Alternative Splicing As an introduction to microarrays.
Review of important points from the NCBI lectures. –Example slides Review the two types of microarray platforms. –Spotted arrays –Affymetrix Specific examples.
Emergent Biology Through Integration and Mining Of Microarray Datasets Lance D. Miller GIS Microarray & Expression Genomics.
Comprehensive Gene Expression Analysis of Prostate Cancer Reveals Distinct Transcriptional Programs Associated With Metastatic Disease Kevin Paiz-Ramirez.
1 Harvard Medical School Transcriptional Diagnosis by Bayesian Network Hsun-Hsien Chang and Marco F. Ramoni Children’s Hospital Informatics Program Harvard-MIT.
Genome of the week - Deinococcus radiodurans Highly resistant to DNA damage –Most radiation resistant organism known Multiple genetic elements –2 chromosomes,
SIGMA: A Platform to Visualize and Analyze DNA Copy Number Microarray Data Raj Chari, PhD Student BC Cancer Research Centre Department of Cancer Genetics.
The Myc Transcription Factor
Tumor genetics Minna Thullberg
Tumorigenesis and Cancer Development Pin Ling ( 凌 斌 ), Ph.D. ext 5632; References: 1.Chapter 23 Cancer in “Molecular Cell Biology”
Apostolos Zaravinos, Myrtani Pieri, Nikos Mourmouras, Natassa Anastasiadou, Ioanna Zouvani, Dimitris Delakas, Constantinos Deltas Department of Biological.
Tumorigenesis to Cancer Development Pin Ling ( 凌 斌 ), Ph.D. ext 5632; References: 1.Chapter 23 Cancer in “Molecular Cell Biology”
Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3.
Jo Anne Zujewski, MD Cancer Therapy Evaluation Program Division of Cancer Diagnosis and Treatment National Cancer Institute May 2011 Breast Cancer Biology.
From motif search to gene expression analysis
Cancer. Regulation of Cell Division Two sets of genes control cell division. –Proto-oncogenes. Code for proteins that promote the cell cycle and prevent.
Finish up array applications Move on to proteomics Protein microarrays.
©Edited by Mingrui Zhang, CS Department, Winona State University, 2008 Identifying Lung Cancer Risks.
Huidi Liu, M.D. & Ph.D Genomics Research Centre Harbin Medical University, China Reduced expression of SOX7 in ovarian cancer: a novel.
Functional Genomics Carol Bult, Ph.D. Course coordinator The Jackson Laboratory Winter/Spring 2012 Keith Hutchison, Ph.D. Course co-coordinator.
Identification of network motifs in lung disease Cecily Swinburne Mentor: Carol J. Bult Ph.D. Summer 2007.
吳 華 席 Hua-Hsi Wu, MD OB/GYN, VGH-TPE Aug 12, 2008
Construction of cancer pathways for personalized medicine | Presented By Date Construction of cancer pathways for personalized medicine Predictive, Preventive.
Apostolos Zaravinos and Constantinos C Deltas Molecular Medicine Research Center and Laboratory of Molecular and Medical Genetics, Department of Biological.
DAVID R. SMITH DR. MARY DOLAN DR. JUDITH BLAKE Integrating the Cell Cycle Ontology with the Mouse Genome Database.
Gene Expression Signatures for Prognosis in NSCLC, Coupled with Signatures of Oncogenic Pathway Deregulation, Provide a Novel Approach for Selection of.
The Role and Mechanism of PPAR  in the Transcriptional Regulation of its Target Genes Jinlu Cai 1, Henry L. Keen 2,Thomas L. Casavant 3,4,5, and Curt.
DAVID R. SMITH DR. MARY DOLAN DR. JUDITH BLAKE Integrating the Cell Cycle Ontology with the Mouse Genome Database.
Notes - Cancer and Cell Division
The Cell Cycle and Cancer. The Cell Cycle Cells go through a series of stages through their life These series of stages is called the cell cycle Each.
DIFFERENTIALLY EXPRESSED GENES AND THEIR ASSOCIATED NETWORKS IN CLEAR-CELL RENAL CELL CARCINOMA (RCC) Apostolos Zaravinos and Constantinos C. Deltas Molecular.
Clustering Algorithms to make sense of Microarray data: Systems Analyses in Biology Doug Welsh and Brian Davis BioQuest Workshop Beloit Wisconsin, June.
Cancer Basics EQ: What does cancer have to do with the cell cycle?
Telomerase, Immortalization and Cancer Eric Bankaitis Cancer Bio 169 March 9, 2006 Fig.[9]
What is cancer? Mitosis- normal cell division Cancer- uncontrolled cell division (carcinoma) –Develops into a tumor Benign- does not spread –(Not Cancerous)
Lecture 11. Topics in Omic Studies (Cancer Genomics, Transcriptomics and Epignomics) The Chinese University of Hong Kong CSCI5050 Bioinformatics and Computational.
Alternative Splicing (a review by Liliana Florea, 2005) CS 498 SS Saurabh Sinha 11/30/06.
Homework #3 is due 11/15 Bonus #2 is posted No class on 11/20.
Case Study: Characterizing Diseased States from Expression/Regulation Data Tuck et al., BMC Bioinformatics, 2006.
Functional Genomics Carol Bult, Ph.D. Course coordinator The Jackson Laboratory Winter/Spring 2011 Keith Hutchison, Ph.D. Course co-coordinator.
NCode TM miRNA Analysis Platform Identifies Differentially Expressed Novel miRNAs in Adenocarcinoma Using Clinical Human Samples Provided By BioServe.
Affymetrix User’s Group Meeting Boston, MA May 2005 Keynote Topics: 1. Human genome annotations: emergence of non-coding transcripts -tiling arrays: study.
Nature as blueprint to design antibody factories Life Science Technologies Project course 2016 Aalto CHEM.
Different microarray applications Rita Holdhus Introduction to microarrays September 2010 microarray.no Aim of lecture: To get some basic knowledge about.
Microarray Technology and Data Analysis Roy Williams PhD Sanford | Burnham Medical Research Institute.
Preliminary data of Non- Small Cell Lung Cancer gene expression pilot study Tõnu Vooder, Kristjan Välk, Andres Metspalu Genoa 2005.
GENETIC BIOMARKERS.
1. SELECTION OF THE KEY GENE SET 2. BIOLOGICAL NETWORK SELECTION
Gene expression.
Biomedical Therapies Foundation Standard 1: Academic Foundation
Dept of Biomedical Informatics University of Pittsburgh
Loyola Marymount University
Loyola Marymount University
Loyola Marymount University
Loyola Marymount University
Loyola Marymount University
Presentation transcript:

Identification of network motifs in lung disease Cecily Swinburne Mentor: Carol J. Bult Ph.D. Summer 2007

Goals  Use genome wide gene expression data to study lung biology  Identify pathways that are characteristic of both normal lung development and lung disease (cancer)  Use normal mouse lung development as a framework for identifying potential lung cancer biomarkers in humans

 Signature pathways could provide insights into the pathology of these diseases  Provide possible targets for diagnostics or treatments Significance

Background: Lung Cancer  Leading cause of cancer deaths in the world  Approximately 160,000 deaths annually in the US  Contributing factors: Smoking (90% of cases), 2 nd hand smoke, asbestos and other inhaled carcinogens  Two Types  Small Cell: rapidly spreading, almost only in smokers  Non-Small Cell: 75% of cases, more slowly progressing and easier to treat than small cell  Little progress has been made in developing new, more effective diagnostic and treatment procedures

Background: Development and Cancer  “Cancer has been called a "developmental disorder" (Dean, 1998) because it involves a disruption of the normal developmental program for cells, in terms of both differentiation and proliferation. It follows that some of the molecular players involved in controlling development might be implicated in causing cancer.” ( Dean, M Cancer as a complex developmental disorder - Nineteenth Cornelius P. Rhoads Memorial Lecture. Cancer Research 58:

Transcriptional Profiling with Microarrays  Provides genome wide gene expression data by measuring the presence of messenger RNA in a sample  Many different platforms, the two most common are spotted arrays and Affymetrix arrays

Lung Development Data Sets  Analyze two mouse lung development time series  Bonner et al. (2003) – inbred A/J mice e14.5, e17.5, birth, 1w, 2w, and 4w  Jackson Laboratory/Children’s Hospital (Boston) – inbred C57Bl/6J mice e11.5, e13.5, e14.5, e16.5 and 5days  Developmental overlap time series Bonner: 14.5e, 17.5e, 1w Jax: 14.5e, 16.5e, 5days Bonner A.E., Lemon W.J., & You M. (2003): Gene expression signatures identify novel regulatory pathways during murine lung development: implications for lung tumorigenesis. Journal of Medical Genetics 40,

Analysis of time series using Short Time Series Expression Miner (STEM) ( Bonner ProfilesJackson Lab Profiles Number of Genes Bonner et al. (2003)JAX/Boston (unpublished)

Enrichment of Biological Processes Represented in STEM gene clusters Cell Adhesion Anatomical Structure System Development Vasculature Development Blood Vessel Development Angiogenesis Combined list of genes with upward trend of expression over development (Bonner et al.) Visual Annotation Display (VLAD) (

Cell Cycle Cell Division Mitotic Cell Cycle DNA Repair RNA Processing Mitosis Regulation of transcription Enrichment of Biological Processes Represented in STEM gene clusters Combined list of genes with downward trend of expression over development (JAX/Boston)

Construct Pathways in IPA  Use Ingenuity Pathways Analysis (IPA) ( to construct pathways based on the genes involved in angiogenesis and cell adhesion Cell Adhesion Angiogenesis

Analysis of Human Lung Cancer Data Set Downloaded microarray data from Gene Expression Omnibus (GEO) (  Dehan and Kaminski (GSE1987) 16 Squamous Cell Carcinoma 7 Adenocarcinoma 9 Normal lung tissue samples

Generate Top Hits List  Log 2 normalize data  Calculate the analysis of variance using Microarray analysis of variance (MAANOVA)  Identify a top-hits list of genes that are significantly up or down regulated  R Statistical Software ( project.org)

VLAD analysis of Human Cancer Genes Up Regulated M Phase Cell cycle process Mitosis Cell division Cell cycle checkpoint DNA replication Cellular metabolic process Chromosome segregation Down Regulated Anatomical structure development System Development Response to Wounding Biological Adhesion Cell Adhesion Cell Communication Cell Morphogenesis Angiogenesis Blood Vessel Morphogenesis Anti-parallels lung development results Up in Development Angiogenesis and Cell Adhesion Down in development Cell cycle

Overlap human lung cancer genes onto angiogenesis and adhesion pathways in IPA Adhesion pathway overlapped with cancer expression Angiogenesis pathway overlapped with cancer expression

Cell Adhesion Pathway  The same overlap was done with a breast cancer top hits list and just 3 genes overlapped in each pathway

 The expression of these 23 genes in lung development and in cancer suggest that they are important to the pathology of lung cancer.  They could serve as potential biomarkers for diagnosis or prognosis of lung cancer. Results of overlap 23 genes from the angiogenesis / adhesion pathways overlapped with both Adenocarcinoma and Squamous gene lists Of those: 6 – mouse lung phenotype in MGI 14 –previously associated with cancer 5 –previously identified as potential cancer biomarker

Summary  Evaluating human cancer genes in the context of normal lung development identifies subsets of biological networks that are likely to be important to disease processes

Further Work  Follow up on candidate biomarkers identified in this study  Perform same comparisons on genes that were down regulated in lung development  Compare lung tumor data for mouse to mouse lung development  Expand approach to other types of cancer and to other lung diseases such as pulmonary fibrosis

Acknowledgements  Carol J. Bult Ph.D.  Benjamin L. King, M.S.  Jon Geiger  Randy O’Rouke  The Jackson Laboratory Summer Student Program  Jane D. Weinberger Endowed Scholarship Fund  The Horace W. Goldsmith Foundation